1. Home
  2. STC vs NVCR Comparison

STC vs NVCR Comparison

Compare STC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STC
  • NVCR
  • Stock Information
  • Founded
  • STC 1893
  • NVCR 2000
  • Country
  • STC United States
  • NVCR Switzerland
  • Employees
  • STC N/A
  • NVCR N/A
  • Industry
  • STC Specialty Insurers
  • NVCR Medical/Dental Instruments
  • Sector
  • STC Finance
  • NVCR Health Care
  • Exchange
  • STC Nasdaq
  • NVCR Nasdaq
  • Market Cap
  • STC 2.0B
  • NVCR 1.9B
  • IPO Year
  • STC N/A
  • NVCR 2015
  • Fundamental
  • Price
  • STC $61.27
  • NVCR $17.60
  • Analyst Decision
  • STC Buy
  • NVCR Buy
  • Analyst Count
  • STC 3
  • NVCR 7
  • Target Price
  • STC $76.67
  • NVCR $32.43
  • AVG Volume (30 Days)
  • STC 181.6K
  • NVCR 1.4M
  • Earning Date
  • STC 07-23-2025
  • NVCR 07-24-2025
  • Dividend Yield
  • STC 3.31%
  • NVCR N/A
  • EPS Growth
  • STC 72.76
  • NVCR N/A
  • EPS
  • STC 2.60
  • NVCR N/A
  • Revenue
  • STC $2,547,588,000.00
  • NVCR $621,711,000.00
  • Revenue This Year
  • STC $11.17
  • NVCR $5.56
  • Revenue Next Year
  • STC $11.31
  • NVCR $9.19
  • P/E Ratio
  • STC $23.23
  • NVCR N/A
  • Revenue Growth
  • STC 11.27
  • NVCR 18.27
  • 52 Week Low
  • STC $58.61
  • NVCR $14.17
  • 52 Week High
  • STC $78.44
  • NVCR $34.13
  • Technical
  • Relative Strength Index (RSI)
  • STC 36.40
  • NVCR 49.74
  • Support Level
  • STC $59.08
  • NVCR $16.81
  • Resistance Level
  • STC $66.93
  • NVCR $18.59
  • Average True Range (ATR)
  • STC 1.71
  • NVCR 0.74
  • MACD
  • STC -0.48
  • NVCR 0.08
  • Stochastic Oscillator
  • STC 11.66
  • NVCR 56.18

About STC Stewart Information Services Corporation

Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: